Key result
XGBoost machine learning outperforms the Kihon Checklist for predicting 1-year functional decline in older HF.
Why the study?
Tools predicting long-term functional trajectories in older patients with heart failure are scarce despite the importance of preserving functional independence.
Does a machine learning model predict functional decline and death more accurately than the Kihon Checklist in older patients hospitalized for heart failure?
Cohort (n=6,382)
Yes
Does a machine learning model predict functional decline and death more accurately than the Kihon Checklist in older patients hospitalized for heart failure?
A machine learning model using clinical and functional metrics at discharge accurately identifies older heart failure patients at high risk for 1-year functional decline, outperforming standard frailty screening.
Answers are grounded in this paper and cite their sources.
ML model may help stratify functional decline risk in older HF patients beyond standard scores; leaves open prospective validation before clinical adoption.
BACKGROUND: Preserving functional independence is critical in older patients with heart failure (HF), yet tools predicting long-term functional trajectories are scarce. AIMS: To develop and validate a machine learning (ML) model predicting functional decline, accounting for the competing risk of mortality. METHODS: We analyzed 6382 older patients (median age, 82 years) from a nationwide prospective cohort (J-Proof HF registry). Patients aged ≥65 years, hospitalized for HF, prescribed rehabilitation, and independent preadmission (Barthel Index [BI] ≥85) were included. An eXtreme Gradient Boosting (XGBoost) model was developed to predict a 1-year 3-class outcome: functional maintenance, functional decline, or death. Functional decline was defined as transitioning to a housebound/bedridden state (equivalent to BI <85) based on a national long-term care scale. Performance was evaluated via nested leave-one-site-out validation and benchmarked against the Kihon Checklist (KCL) frailty screening tool. RESULTS: At 1 year, 32.5% of patients experienced functional decline and 14.5% died. A parsimonious Top-10 XGBoost model (including maximum gait speed, discharge BI, preadmission frailty score, and age) demonstrated good discrimination (area under the receiver operating characteristic curve [AUC], 0.75; 95% confidence interval [CI], 0.74-0.76), significantly outperforming KCL-based scores (AUC, 0.66-0.69; P < .001). The model identified 4 risk phenotypes, including a "low-mortality/high-decline" group (n = 1732) with a 57.0% functional decline rate despite an 89.0% survival probability. CONCLUSION: This ML model accurately identifies older HF patients at high risk for functional decline despite favorable survival, enabling targeted rehabilitation to preserve quality of life.
No takes yet. Share an insight, caveat, or question.
Yamada et al. (2026) conducted a cohort in Heart failure (n=6,382). eXtreme Gradient Boosting (XGBoost) machine learning model vs. Kihon Checklist (KCL) frailty screening tool was evaluated on 1-year 3-class outcome: functional maintenance, functional decline, or death (AUC 0.75, 95% CI 0.74-0.76, p=< .001). An eXtreme Gradient Boosting model predicted 1-year functional decline in older heart failure patients better than the Kihon Checklist (AUC 0.75 vs 0.66-0.69; P<.001).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: